Quantamental Technologies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-836
Closed -$371K 385
2023
Q2
$371K Sell
836
-686
-45% -$316K 0.15% 226
2023
Q1
$700K Buy
+1,522
New +$724K 0.38% 72
2021
Q3
Sell
-551
Closed -$210K 318
2021
Q2
$210K Buy
+551
New +$211K 0.19% 215
2019
Q4
Sell
-1,903
Closed -$457K 685
2019
Q3
$457K Buy
+1,903
New +$521K 0.15% 200
2019
Q2
Sell
-2,800
Closed -$804K 1556
2019
Q1
$804K Buy
2,800
+2,602
+1,314% +$753K 0.37% 26
2018
Q4
$52K Buy
+198
New +$54.4K 0.03% 758

Other funds holding ELV

Quantamental Technologies's ELV Position: Q3 2023 in Review

Quantamental Technologies sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 836 shares — an estimated $371K sold.

Quantamental Technologies first reported a position in ELV in Q4 2018 and held it in 6 quarters. The position peaked at $804K in Q1 2019. 1,524 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Quantamental Technologies reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 836 Elevance Health shares in Q3 2023, an estimated $371K.
  • Quantamental Technologies first reported a position in Elevance Health in Q4 2018 and held it in 6 quarters.
  • Quantamental Technologies's Elevance Health position peaked at $804K in Q1 2019.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.